Lactate dehydrogenase as a biomarker in brochoalveolar lavage of patients with lung cancer

M. Saba, A. Emad (shiraz, Islamic Republic Of Iran)

Source: Annual Congress 2009 - Biological and clinical markers in lung cancer
Session: Biological and clinical markers in lung cancer
Session type: Thematic Poster Session
Number: 2678
Disease area: Thoracic oncology

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Saba, A. Emad (shiraz, Islamic Republic Of Iran). Lactate dehydrogenase as a biomarker in brochoalveolar lavage of patients with lung cancer. Eur Respir J 2009; 34: Suppl. 53, 2678

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Lactate dehydrogenase levels in bronchoalveolar lavage fluid in the diagnosing of active pulmonary tuberculosis
Source: Eur Respir J 2002; 20: Suppl. 38, 582s
Year: 2002

Evaluation of IL-6 level in serum and bronchoalveolar lavage fluid of patients with non-small cell lung cancer (NSCLC)
Source: Annual Congress 2011 - Biomarkers and other new methods for lung cancer
Year: 2011

Evaluation of IL-10 level in serum and bronchoalveolar lavage fluid of patients with non-small cell lung cancer (NSCLC)
Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer
Year: 2013

TNF-alpha, IL-1 and IL-6 concentration in bronchoalveolar lavage fluid (BALF) of non-small cell lung cancer (NSCLC)
Source: Annual Congress 2013 –New methods for diagnostic workup of lung cancer
Year: 2013

Cytochrome c levels in serum and bronchoalveolar lavage fluid in lung injury
Source: Eur Respir J 2006; 28: Suppl. 50, 568s
Year: 2006

Inflammasome pathway activation in patients with non-small cell lung cancer (NSCLC): A bronchoalveolar lavage fluid study
Source: Annual Congress 2013 –Pathogenesis and risk of lung cancer
Year: 2013


Bronchoalveolar lavage in patients with acute lung toxicity after chemo-radiotherapy for lung cancer
Source: Eur Respir J 2003; 22: Suppl. 45, 29s
Year: 2003

Evaluation of IL-33 level in serum and bronchoalveolar lavage fluid of patients with non-small cell lung cancer (NSCLC)
Source: International Congress 2014 – Biology and pathology of thoracic tumours
Year: 2014

Mast cell tryptase concentration measured with B12 antibody-based immunoassay in bronchoalveolar lavage fluid from patients with interstitial lung disease
Source: Eur Respir J 2004; 24: Suppl. 48, 10s
Year: 2004

Cytotoxic phenotype of lymphocytes in bronchoalveolar lavage (BAL) of patients with non-small cell lung cancer (NSCLC)
Source: International Congress 2017 – Lung cancer - basic science: the latest results from the bench
Year: 2017

Inflammatory proteins in bronchoalveolar lavage of lung transplanted patients
Source: Annual Congress 2009 - Human and experimental lung transplantation: novel findings
Year: 2009

Elevated TGF- b1 concentration in bronchoalveolar lavage fluid from patients with primary lung cancer
Source: Eur Respir J 2002; 20: Suppl. 38, 585s
Year: 2002

Net inflammatory activity of bronchoalveolar lavage fluid (BALF) from patients following lung transplantation
Source: Eur Respir J 2002; 20: Suppl. 38, 348s
Year: 2002

Matrix metalloproteinase-9 (MMP-9) elevated in serum, but not in bronchial lavage in lung cancer patients
Source: Annual Congress 2013 –New methods for diagnostic workup of lung cancer
Year: 2013

Tumour markers in bronchoalveolar lavage and its diagnostic contribution in lung cancer not visible through regular fibrobronchoscopy
Source: Eur Respir J 2002; 20: Suppl. 38, 276s
Year: 2002

Coagulation activity in bronchoalveolar lavage fluid and blood of interstitial lung diseases patients
Source: Eur Respir J 2003; 22: Suppl. 45, 255s
Year: 2003

Coagulation activity of bronchoalveolar lavage fluid and blood in patients with interstitial lung diseases
Source: Eur Respir J 2002; 20: Suppl. 38, 174s
Year: 2002

Detection of MAGE-A expression in induced sputum and bronchial lavage fluid of patients with lung cancer
Source: Eur Respir J 2003; 22: Suppl. 45, 362s
Year: 2003

Diagnostic value of tumor markers and cells population in bronchoalveolar lavage in lung cancer
Source: Eur Respir J 2003; 22: Suppl. 45, 37s
Year: 2003

Level of cytokines in bronchoalveolar lavage fluid (BALF) in patients with professional lung diseases and COPD
Source: Eur Respir J 2001; 18: Suppl. 33, 67s
Year: 2001